ICU Medical director sells 378 company shares

ICU Medical Inc. director Elisha W. Finney sold common shares, disposing of 378 shares of ICU Medical Inc. common stock on 2026-08-11 in an open market or private transaction at a weighted average price of $182.4818 per share.

Accepted by SEC EDGAR 08/11/2026 - 05:59 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

ICU Medical Inc. director Elisha W. Finney sold common shares, disposing of 378 shares of ICU Medical Inc. common stock on 2026-08-11 in an open market or private transaction at a weighted average price of $182.4818 per share. The trades occurred in a price range from $182.4808 to $182.5701. Following this transaction, Finney directly holds 4,871 common shares of ICU Medical Inc.

Insider Trade Summary

Net Seller: 378 shares

Net Sell 1 txn

Insider FINNEY ELISHA W

Role Director

Sold 378 shs ($69K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	378	$182.4818	$69K

Holdings After Transaction: Common Stock — 4,871 shares (Direct)

Footnotes (1)

1. F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.4808 to $182.5701, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Key Figures

Shares sold: 378 shares Weighted average sale price: $182.4818 per share Sale price range low: $182.4808 per share +2 more

5 metrics

Shares sold 378 shares Non-derivative common stock sale on 2026-08-11

Weighted average sale price $182.4818 per share Reported for ICUI common stock sale

Sale price range low $182.4808 per share Lowest price in multiple sale transactions

Sale price range high $182.5701 per share Highest price in multiple sale transactions

Shares held after transaction 4,871 shares Director’s direct common stock holdings post-sale

Key Terms

weighted average price, open market or private transaction, non-derivative

3 terms

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open market or private transaction financial

"Transaction code S indicates a sale in open market or private transaction."

non-derivative financial

"The transaction_type is non-derivative for common stock."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ICU Medical (ICUI) report for Elisha W. Finney?

ICU Medical (ICUI) reported that director Elisha W. Finney sold 378 common shares on 2026-08-11. The sale was reported as an open market or private transaction, with details filed on Form 4.

At what price did Elisha W. Finney sell ICUI shares?

The reported weighted average sale price was $182.4818 per ICUI share. According to the disclosure, the 378 shares were sold in multiple trades at prices ranging from $182.4808 to $182.5701 per share.

How many ICU Medical (ICUI) shares does Elisha W. Finney hold after the sale?

After the reported sale, Elisha W. Finney directly holds 4,871 shares of ICU Medical common stock. This figure reflects her post-transaction position as disclosed in the Form 4 filing.

Was the ICUI insider sale by Elisha W. Finney under a Rule 10b5-1 plan?

The filing’s 10b5-1 checkbox is not marked as using a trading plan. The sale is described as a standard open market or private transaction, with no Rule 10b5-1 plan noted in the disclosure.

How many ICUI shares were sold in total in this insider transaction?

The Form 4 reports that 378 ICU Medical common shares were sold in this transaction. All shares are classified as directly owned, non-derivative securities, and were executed on 2026-08-11.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FINNEY ELISHA W

(Last) (First) (Middle)

951 CALLE AMANECER

(Street)

SAN CLEMENTE CALIFORNIA 92673

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ICU MEDICAL INC/DE [ ICUI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/11/2026		S		378	D	$182.4818(1)	4,871	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.4808 to $182.5701, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

	By: Paula Darbyshire, Attorney-in-Fact For: Elisha W Finney	08/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)